Unknown

Dataset Information

Biomarkers in patients with heart failure and central sleep apnoea: findings from the SERVE-HF trial.


ABSTRACT:

Aims

The Treatment of Sleep-Disordered Breathing with Predominant Central Sleep Apnoea by Adaptive Servo Ventilation in Patients with Heart Failure trial investigated the effects of adaptive servo-ventilation (ASV) (vs. control) on outcomes of 1325 patients with heart failure and reduced ejection fraction (HFrEF) and central sleep apnoea (CSA). The primary outcome (a composite of all-cause death or unplanned HF hospitalization) did not differ between the two groups. However, all-cause and cardiovascular (CV) mortality were higher in the ASV group. Circulating biomarkers may help in better ascertain patients' risk, and this is the first study applying a large set of circulating biomarkers in patients with both HFrEF and CSA.

Methods and results

Circulating protein-biomarkers

SUBMITTER: Ferreira JP 

PROVIDER: S-EPMC7160494 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature